Fortune Financial Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.02M | Buy |
29,212
+694
| +2% | +$47.9K | 1.62% | 21 |
|
|
2025
Q1 | $1.98M | Buy |
28,518
+1,132
| +4% | +$78.6K | 1.71% | 19 |
|
|
2024
Q4 | $2.36M | Buy |
27,386
+568
| +2% | +$48.9K | 2.14% | 14 |
|
|
2024
Q3 | $3.19M | Buy |
26,818
+34
| +0.1% | +$4.05K | 2.89% | 6 |
|
|
2024
Q2 | $3.82M | Buy |
26,784
+520
| +2% | +$74.2K | 2.34% | 8 |
|
|
2024
Q1 | $3.37M | Sell |
26,264
-825
| -3% | -$106K | 2.14% | 10 |
|
|
2023
Q4 | $2.8M | Buy |
27,089
+339
| +1% | +$35.1K | 1.96% | 12 |
|
|
2023
Q3 | $2.43M | Buy |
26,750
+14
| +0.1% | +$1.27K | 1.86% | 16 |
|
|
2023
Q2 | $2.16M | Buy |
+26,736
| New | +$2.16M | 1.62% | 17 |
|